Foster Dykema Cabot & Partners, LLC Merck & Co., Inc. Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.19 Trillion
- Q3 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 12,230 shares of MRK stock, worth $1.2 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
12,230
Previous 9,549
28.08%
Holding current value
$1.2 Million
Previous $1.19 Billion
17.57%
% of portfolio
0.12%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,797Shares Held
1.92BCall Options Held
13.3MPut Options Held
10.6M-
Vanguard Group Inc Valley Forge, PA250MShares$24.6 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$11.6 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.14 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.83 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $250B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...